Background: Micronesians are a rapidly growing population in Hawaii and the continental U.S. Hepatitis B is prevalent in Micronesia, but the consequences in those migrating to the U.S. are unclear. This study characterizes hepatocellular carcinoma in Micronesians with comparisons to other Pacific Islanders. Methods: A retrospective evaluation was undertaken of 40 Micronesian and 142 Non-Micronesian Pacific hepatocellular carcinoma patients diagnosed in a large clinical practice in Hawaii from 1993-2017. Results: All Micronesians were born outside of the U.S. Micronesians were younger at diagnosis (52.0 vs. 60.2 years), had higher rates of hepatitis B (80% vs. 31.2%), a family history of hepatocellular carcinoma (17.5% vs. 4.4%) and more tumors <5 cm (64.1% vs. 45.2%). Non Micronesian Pacific Islanders had higher rates of Hepatitis C (48.6% vs. 22.5%) and hypertension (61.7% vs. 32.4%). There was no difference in the proportions of screen-detected tumors, those meeting Milan criteria, tumor stage, or liver function. Micronesians had better 5-year survival rates (48% vs. 16.7%). Conclusion: Hepatocellular carcinoma in Micronesians is primarily Hepatitis B-related. Micronesians were equally likely to have hepatocellular carcinoma found with screening, undergo transplant and had better survival. Our study emphasizes the need for hepatitis B screening and hepatocellular carcinoma surveillance in Micronesians.
Introduction
Hepatocellular Carcinoma (HCC) is currently the fifth leading cause of cancer death in the United States, with an estimated incidence of 8.6 per 100,000 that continues to rise by approximately 2.7% annually [1] . HCC is more common in men, and is seen most often in the Asian/Pacific Islander and American Indian/Alaskan Native populations. The most common risk factors for HCC include underlying chronic hepatitis B and C infections (~80% of cases), cirrhosis of any cause and other chronic liver disease [2] . From 2010-2014, Hawaii had the highest incidence rate of HCC (11.29/100,000 people) [1] , which is likely due to the large Asian/Pacific Islander population and continuous immigration from Wake Island. The U.S. Government Accountability Office estimates that about 56,000 Micronesians reside in the U.S. [3] , with an estimated 15,000 Micronesians now living in Hawaii. Although they comprise only 1% of Hawaii's population [4] , annual healthcare expenditure in 2007 on Micronesians was estimated at over $37 million [5] . Emigration from Micronesia is driven by multiple factors including decreased U.S. funding, scarce employment opportunities, natural disasters, and a lack of health infrastructure. The Compact of Free Association (COFA) agreement between the U.S. and the Free Associated States (including the Federated States of Micronesia, Marshall Islands, and Palau) allows citizens to live, work and study in the U.S. permanently without a visa, further encouraging migration. In a survey of Micronesian migrants, Hezel et al. found that among those migrating to Hawaii, 11% moved specifically for medical reasons, more so than any other site of immigration [6] . The health status of Micronesians is complex and characterized by both non-communicable diseases as seen in the developed nations such as obesity, diabetes mellitus type 2, hypertension and heart disease, and significant infectious disease burden [7] . For HCC, Palafox et al. identified hepatitis B and alcohol abuse as major risk factors in Micronesians [8] .
Micronesian migration to Hawaii continues to increase and the health services utilization by this population is significant [6] . While infectious diseases including hepatitis B have been studied in this population, there have been no studies characterizing HCC in Micronesians. We aim to describe the disease course in these patients from risk factors to survival, and then compare these factors with a group of Non-Micronesian Pacific Islanders (NMPI).
Methods

Study Participants
This is a retrospective study of a prospectively collected database of patients with HCC. A total of 1206 patients were referred to a group of surgeons affiliated with HCC not found on screening was either found with symptoms or asymptomatically with imaging done for unrelated reasons.
Data Collection
Statistical Analysis
All analyses were performed using Graphpad Prism (GraphPad Prism version 7.00 for Mac, GraphPad Software, La Jolla California USA, www.graphpad.com).
Categorical variables were analyzed using Fisher's test and numerical variables
were analyzed using unpaired two-tailed t-tests. Survival time was calculated as time from HCC diagnosis to death from all causes of mortality. The Kaplan-Meier method was used to calculate median survival and overall survival for both populations. P values < 0.05 were considered significant.
Results
We analyzed 182 HCC patients that self-identified as either Micronesian or Pa- (Table 3 ) did not differ between the two populations.
The treatment of HCC (Table 4 ) did not significantly differ between the 
Discussion
The HCC in Micronesians was predominantly hepatitis B related. This was likely vertically transmitted, as there was also a significantly higher family history of HCC. While children in the U.S. have routinely received the hepatitis B vaccina-tion for several decades, vaccination in some Asian and Pacific Island countries has not been uniformly practiced. Prior to the implementation of hepatitis B vaccination between 1986-1989, more than 70% of children on the Micronesian island of Chuuk were infected by ages 8 -9 [9] . Despite efforts to more consistently vaccinate Micronesian children, completion of the vaccine series is still a challenge. As a result, approximately 15% of Micronesians are now chronically infected with hepatitis B and this is the primary risk factor for HCC [10] . Hopefully greater efforts at vaccination can reduce the incidence of HCC in the next generation of Micronesians, but it may take several decades to fully realize this benefit.
In the past, the primary risk factors for HCC were viral hepatitis and alcoholic cirrhosis, however the increasing incidence of HCC despite better control of hepatitis B and C may be attributed to the effect of metabolic factors, fatty liver disease and non-alcoholic steatohepatitis [11] . In this study, metabolic risk fac- This study is limited in that it represents data from a single center with a relatively small sample size. Comparing Micronesians only to other Pacific Islanders may have limited our study's applicability, however we wanted to compare a relatively recently immigrated group to a more established population of Pacific Islanders. It is also possible that we have selected a group of inherently more motivated and financially secure Micronesians as they had the resources to make the trip from Micronesia to Hawaii. In spite of these limitations, our study describes a unique population that has not been previously characterized in the literature in terms of HCC. Because we have Hawaii's only dedicated liver center that sees approximately 70% of Hawaii's HCC cases, it is likely that we captured the majority of HCC cases in Micronesians. Finally, it is important that the U.S. is aware of this ethnic group, as Micronesians are rapidly migrating across the rest of the U.S., especially to the Midwest (Missouri, Arkansas) in search of entry-level jobs and a more affordable cost of living [22] [23] . Health issues in this ethnic group will need to be addressed.
It is remarkable that Micronesians, a new migrant population, received curative treatments on par with and had better survival than U.S.-born Pacific Islanders. Previous studies on ethnic disparities in HCC cite culturally competent education and effective communication as key factors to improve care for minorities [20] . In Hawaii, we have several health clinics that readily refer patients to our liver center and are equipped with interpreters who speak various Micronesian dialects. It is also helpful that this liver center is located on the same floor as the transplant center and the hepatobiliary/transplant surgeons, which likely facilitated navigation of the healthcare system for this population. We also use Micronesian former patients to guide new patients through the process, providing translation, cultural support and mentorship.
Conclusion
Compared to Non-Micronesian Pacific Islanders, Micronesians were as likely to have HCC discovered with screening, undergo transplant and had better survival. This study highlights the need for hepatitis B screening and HCC surveillance in Micronesians and it further demonstrates how a group of immigrants were able to overcome barriers, undergo treatment and have outcomes comparable to U.S.-born Pacific Islanders. We will need to continue efforts to monitor this group of immigrants with a high burden of liver disease. Perhaps other centers in the U.S. can develop similar strategies for other ethnic minorities and determine if this can reduce disparities in access to cancer care.
